Lasa Supergenics Share Price

Lasa Supergenics Share Price

NSE: LASA
|
Pharmaceuticals
|
S Cap
₹ 6.50
-₹0.19 (-2.84%)
1D
Last updated 09 Sep, 2026, 15:29 IST

Lasa Supergenics Share Price Today

As of 9 Sep 2026, Lasa Supergenics share price is ₹6.50. The stock opened at ₹6.71, compared to its previous close of ₹6.69. During today's trading session, Lasa Supergenics share price moved in the range of ₹6.45 to ₹6.71, with an average price of ₹6.58 for the day. Looking at its last 52-week, the stock has touched a low of ₹5.67 and a high of ₹14.08. On the performance front, Lasa Supergenics share price has declined by 15.21% over the last six months and is down 37.18% on a year-on-year basis.

₹6.45
2.84% down today
₹6.71
1D LOW
1D HIGH

Lasa Supergenics Returns Calculator

Circuit
L
H
₹5.36
₹8.02
52-week
L
H
₹5.67
₹14.08

About Lasa Supergenics

Lasa Supergenics Share Price
ISIN
INE670X01014
Sector Market Cap
₹ 33.62 Cr

Lasa Supergenerics Limited is an India-based company, which is engaged in the business of manufacturing active pharmaceutical ingredients (API) bulk drugs products. The Company is engaged in the business of manufacturing, trading, producing, processing, preparing, and treating chemicals, API, pharmaceuticals, drugs, and others. It specializes in catalyst chemistry and manufactures anthelmintic/ veterinary API products with production capabilities and product categories in India. The Company's products include API products, other API products, animal feed ingredients and reagents for therapeutic use. Its API products include Fenbendazole, Toldimphos sodium, Cyromazine, Albendazole, Riclabendazole, Rafoxanide, Ornidazole, 2,6-Diiodo-4-Nitrophenol, Ricobendazole, Oxfendazole, Closantel Base, Closantel sodium, Nitroxynil, Halquinol, and Oxyclozanide. The Company's manufacturing facility is located in Chiplun, Maharashtra.

Lasa Supergenics Financial Highlights

  • Revenue: Lasa Supergenics reported revenue of ₹25.34 crore in FY26 vs ₹147.46 crore in FY25. It showed a decrease of 82.82% on a yearly basis.
  • Operating Profit: Lasa Supergenics reported an operating loss of ₹34.61 crore in FY26 vs ₹19.38 crore in FY25. It showed a decrease of 78.59% on a year-on-year basis.
  • Net Profit: Lasa Supergenics reported a net loss of ₹34.09 crore in FY26 vs ₹14.76 crore in FY25. It showed a decrease of 130.96% on a yearly basis.

Lasa Supergenics Quarterly Result Highlights

  • Lasa Supergenics reported revenue of ₹1.33 crore in Jun 2026, compared with ₹0.09 crore in Mar 2026, representing an increase of 1,577.78% on a quarter-on-quarter (QoQ) basis.
  • Lasa Supergenics reported an operating loss of ₹3.47 crore in Jun 2026, compared with ₹3.98 crore in Mar 2026, representing an increase of 12.81% on a quarter-on-quarter (QoQ) basis.
  • Lasa Supergenics reported a loss of ₹3.58 crore in Jun 2026, compared with ₹4.16 crore in Mar 2026, reflecting an increase of 13.94% on a QoQ basis.
  • The earnings per share (EPS) of Lasa Supergenics stood at ₹2.95 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
53.65%
FII
0.00%
Other DII
0.00%
Retail and other
46.35%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Jun 20250.00%
Sep 20250.00%
Dec 20250.00%
Mar 20260.00%
Mkt Cap Cr
33.62
P/E
-2.03
P/B
0.68
ROE
-26.30%
D/E
0.20
ROCE
-22.21%
Div. Yield
0.00%
EPS(TTM)
-6.80
Turnover
0.10
EV/EBITDA
-4.71
Net Margin
0.00%
Op. Margin
0.00%
ROA
-24.96%
Quick Ratio
0.00
Curr. Ratio
1.49
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Lasa Supergeneri has not beaten FD return of 7%
Step 1 of 5
Valuation
Overvalued
Lasa Supergeneri appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,51,339.0037.255.4013.74%0.6117.33%93.240.85%0.4810.90
Divis Laboratories2,54,068.0086.8615.1615.32%0.0019.56%629.490.31%0.5598.19
Torrent Pharmaceuticals1,88,767.0087.5622.4525.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,14,713.0024.984.2318.59%0.3117.35%237.300.09%0.3335.38
Cipla1,11,804.0033.323.2511.27%0.0014.95%423.360.94%0.4543.52
Laurus Labs1,05,118.0096.4119.8316.77%0.4016.14%97.200.10%0.6713.72
Lupin96,574.5017.404.3023.76%0.0424.88%659.000.85%0.57129.18
Mankind Pharma95,242.0046.065.8411.74%0.3413.13%396.980.04%0.4449.37
Dr. Reddy's Laboratories96,113.4030.192.5211.07%0.1812.54%377.950.70%0.4138.68
Aurobindo Pharma97,008.7026.142.569.25%0.1911.76%394.820.24%0.3841.58

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Lasa Supergenics Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹142.45₹104.34₹129.57₹137.13
Other Income₹5.01₹0.10₹1.80₹0.27
Total Revenue₹147.46₹104.43₹131.37₹137.40
Total Expenses₹151.17₹114.77₹153.74₹135.68
Profit Before Tax-₹19.38-₹19.11-₹42.27-₹6.14
Tax-₹4.63₹2.62-₹3.64-₹0.81
Profit After Tax-₹14.76-₹21.73-₹38.62-₹5.33
EPS - Basic-₹2.95-₹4.34-₹7.71-₹1.06
EPS - Diluted-₹2.95-₹4.34-₹7.71-₹1.06

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax-₹19.38-₹19.11-₹22.37₹1.72
Income before WC changes₹9.16-₹10.69-₹26.44₹8.22
Change in Assets-₹1.71₹6.82₹12.24₹5.58
Change in Liabilities-₹10.27₹6.01-₹3.06-₹2.00
Change in WC-₹11.98₹12.83₹9.18₹3.59
Cash flow from Operations-₹2.82₹2.14-₹17.30₹9.21
Cash flow from Investing₹8.15-₹0.40₹11.19-₹2.91
Cash flow from Financing-₹5.66-₹1.93-₹4.16-₹0.04
Total Cash Flow-₹0.33-₹0.19-₹10.27₹6.26
Cash (Start of the year)₹0.61₹0.80₹11.07₹4.81
Cash (End of the year)₹0.28₹0.61₹0.80₹11.07

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹69.02₹112.98₹124.63₹142.87
Current Assets₹32.51₹37.89₹39.22₹66.30
Total Assets₹101.53₹150.87₹163.85₹209.17
Current Liabilities₹17.15₹48.87₹42.73₹44.75
Net Current Asset₹15.36-₹10.98-₹3.51₹21.55
Non-Current Liabilities₹0.66₹5.32₹2.84₹6.54
Equity Capital₹83.71₹96.68₹118.29₹157.88
Total Equity & Liabilities₹101.53₹150.87₹163.85₹209.17
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 0
Buy orders: 0%
Sell orders: 0%
Bearish
2
Neutral
4
Bullish
2
Neutral
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
36.22
Neutral
ATR (14)
0.45
Neutral
STOCH(9,6)
10.98
Bullish
STOCH RSI (14)
3.67
Bullish
ADX(9)
38.82
Bearish
UO(9)
33.82
Neutral
ROC(12)
-7.08
Bearish
WillR(14)
-75
Neutral
Period
Simple value
Exponential vaue
5D
6.74
6.74
10D
6.83
6.83
20D
7.04
6.97
50D
7.19
7.19
100D
7.55
7.45
Volume trend — traded volume by day
9 Sep0L
8 Sep0L
7 Sep0L
4 Sep0L
3 Sep0L
2 Sep0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
Lasa Supergenics Share Price
Lasa Supergenics
Pharmaceuticals
Add Stock
Add Another

Lasa Supergenics Share Price FAQs

Lasa Supergenics share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837